Eskitis Institute at Griffith University Chooses Evotec's Opera as a HCS Platform

Evotec Technologies GmbH and the Eskitis Institute, Griffith University, have announced the installation of an Opera™ system as a platform to provide Eskitis' with high-content screening.

"We are extremely proud to be chosen by Eskitis as technology provider," stated Dr Guenter Bauer, CBO at Evotec Technologies GmbH.

"We see an increasing demand for fully automated microscopy in academia research to cope with the high throughput experimentation requirements of modern cell biology research."

"The Opera is the ideal tool for such purpose because it provides true confocality and the desired speed plus great flexibility with respect to options and upgrades, e.g. excitation / emission combinations, imaging magnification, on-board dispensing, environmental control, or plate handling."

"The Opera will further enhance the capabilities of Eskitis in the area of high content cell biology by providing a platform that will enable research into cellular functions at a speed and throughput not previously available to Australian researchers," comments Professor Ron Quinn, Professor & Director of Eskitis Institute for Cell and Molecular Therapies, Griffith University.

"It is also an important advance in the drug discovery process as it is able to provide multiple readouts on how a potential drug may effect the growth and function of a cell."